UCSF’s Chancellor, Susan Desmond-Hellmann, MD, MPH, was selected by
FORBES as one of its 7 Most Powerful Innovators of 2009. You can read
the story here.
According to the article, Desmond-Hellmann’s most influential
innovations were the blockbuster cancer drugs Avastin and Herceptin. What makes Desmond-Hellmann an innovator?
legions of cancer patients. While president of product development at
Genentech from 2004 to April 2009, she played an integral role in the
selection, testing and development of Avastin, a colon cancer drug with
annual sales of $9 billion, and Herceptin, a breast cancer drug with
sales of $7.8 billion. In August 2009 she became the chancellor of
UCSF, a powerhouse in medical research, where she aims to continue
fostering innovation in health care and science".